Diabetes Management: Treatment and Lifestyle Modifications
For optimal diabetes management, metformin should be used as first-line therapy, followed by SGLT2 inhibitors or GLP-1 receptor agonists as second-line options, along with at least 150 minutes of moderate-to-vigorous aerobic activity per week and a diet emphasizing fiber-rich foods with a low glycemic load. 1
Pharmacological Management
First-Line Treatment
- Metformin is the optimal first-line medication for most patients with type 2 diabetes 1
- Start at a low dose and gradually titrate to minimize gastrointestinal side effects
- Appropriate for patients with eGFR ≥30 ml/min per 1.73 m²
- May cause metallic taste in approximately 3% of patients when starting treatment 2
- Periodic testing of vitamin B12 levels is recommended for patients on long-term metformin therapy 1
Second-Line Treatment Options
- SGLT2 inhibitors or GLP-1 receptor agonists are preferred second-line options due to their proven cardiorenal benefits 1
- These medications provide cardiovascular protection and weight reduction benefits
- GLP-1 receptor agonists are particularly beneficial for patients with established cardiovascular disease
Combination Therapy Considerations
- When combining medications, be aware of potential interactions:
Glycemic Monitoring and Targets
- Use HbA1c to monitor glycemic control with individualized targets ranging from <6.5% to <8.0% 1
- Check HbA1c quarterly when therapy changes or targets are not met 1
- Reevaluate medication regimen every 3-6 months 1
Lifestyle Modifications
Physical Activity Recommendations
- Aerobic Exercise: At least 150 minutes of moderate-to-vigorous intensity aerobic activity per week, spread over at least 3 days with no more than 2 consecutive days without activity 1
- Resistance Training: 2-3 sessions per week on non-consecutive days, including at least one set of five or more different exercises involving large muscle groups 1
- Break Sedentary Time: Interrupt prolonged sitting every 30 minutes with brief activity for blood glucose benefits 1, 4
Dietary Recommendations
- No single ideal macronutrient distribution exists for all people with diabetes 1
- Key dietary principles:
- Prioritize carbohydrates from vegetables, fruits, legumes, whole grains, and dairy products 1
- Emphasize foods higher in fiber and lower in glycemic load 1
- Avoid sugar-sweetened beverages to control weight and reduce cardiovascular risk 1
- Consider meal timing and sequence: eating protein and vegetables before carbohydrates can moderate glucose levels 4
- Consume most carbohydrates earlier in the day 4
- Limit sodium to <2,300 mg/day (further restriction for those with hypertension) 1
- If consuming alcohol, limit to one drink per day for women and two for men, being aware of increased hypoglycemia risk 1
Weight Management
- For overweight or obese individuals, aim for weight loss of ≥5% through calorie reduction and lifestyle modification 1
Special Considerations and Pitfalls
Exercise Safety Precautions
- Hypoglycemia Risk: Carefully monitor blood glucose when exercising, especially for those on insulin or insulin secretagogues 5
- Timing of Exercise:
Medication-Related Considerations
- Metformin Storage: Store at 68ºF to 77ºF (20ºC to 25ºC) 2
- Pioglitazone Monitoring: Monitor for fluid retention and liver function; do not initiate if patient has active liver disease or elevated transaminases 3
- Hypoglycemia Prevention: When combining medications that increase hypoglycemia risk (especially insulin with other agents), adjust dosages appropriately 1, 3
Comprehensive Care
- Annual comprehensive foot examination 1
- Annual dilated eye examination 1
- Annual nephropathy screening with urine albumin-to-creatinine ratio 1
- Blood pressure check at every routine visit 1
- Referral for individualized Medical Nutrition Therapy, preferably provided by a registered dietitian 1
By following these evidence-based recommendations for medication management and lifestyle modifications, patients with diabetes can achieve better glycemic control and reduce the risk of diabetes-related complications.